Clinical Trials Directory

Trials / Sponsors / Schering-Plough

Schering-Plough

Industry · 10 registered clinical trials.

StatusTrialPhaseStarted
CompletedAssessment of the Effectiveness of OLMETEC® and OLMETEC PLUS® for Treatment of Hypertension in Stage I and II
Hypertension
—2007-04-01
CompletedA Multicenter, Randomized, Controlled Trial of SCH 619734 for the Treatment of Chemotherapy-Induced Nausea and
Nausea, Vomiting
Phase 22006-09-01
TerminatedStudy of Nasonex® in Improving Sleep Disturbances Related to Perennial Allergic Rhinitis (Study P04909)(TERMIN
Perennial Allergic Rhinitis
Phase 42006-09-01
CompletedSatisfaction in Patients Receiving the PegIntron Pen Plus Rebetol for Hepatitis C (Study P04244)(COMPLETED)
Hepatitis C, Chronic, Hepacivirus
—2005-10-01
CompletedPEG-IFN Alfa-2b Plus Ribavirin for Treatment of Mexican naïve Patients With Chronic Hepatitis C Infected With
Hepatitis C, Chronic
Phase 42005-06-01
WithdrawnA Safety and Efficacy Trial Evaluating the Use of Fondaparinux in Percutaneous Coronary Intervention (PCI)(631
Myocardial Infarction, Coronary Disease
Phase 22003-04-01
CompletedSafety and Effectiveness of PEG-Intron in HIV-Infected Patients
HIV Infections
Phase 22000-03-01
CompletedSafety and Effectiveness of Fluconazole Versus SCH 56592 to Treat Thrush in HIV-Positive Patients
Candidiasis, Oral, HIV Infections
Phase 31998-08-01
CompletedPhase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis
Cytomegalovirus Retinitis, HIV Infections
Phase 3—
CompletedA Comparison of SCH 56592 and Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive
Candidiasis, Oral, HIV Infections
Phase 2—